Acino Holding AG (Acino) formerly known as Schweizerhall Holding AG is a pharmaceutical group, principally engaged in the development, registration and manufacture of generic and innovative pharmaceuticals by using its advanced drug delivery technologies. The advanced drug technologies also holds its patents. The company supplies its solid oral dosage forms along with modified release of the active ingredient, transdermal therapeutic patches and biodegradable, subcutaneous implants to major pharmaceutical companies across Europe. Acino is headquartered in Basle, Switzerland.

Street: 
Erlenstrasse 1
City: 
Basle
Postcode: 
4058
Federal State : 
Switzerland
WebSite: 
acino-pharma.com
Fax: 
41-61-3386080

Company Index Score

Current Index Score Historical Index Score
  • Acino Holding AG currently scores 50 % in the index.
  • Acino Holding AG is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Acino Holding AG is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets